Welcure Drugs & Pharmaceuticals (BSE: 524661) is a Ahmedabad, Gujarat-based company in the Non-Prescription Drugs industry. With a market capitalisation of ₹22 Cr, it ranks #4,539 by market cap among the 6,189 Indian listed companies on FinBizNet, and #9 of 9 in Non-Prescription Drugs. At ₹0.18 (as of 26 Oct 2026), the share price is 76.6% below its 52-week high of ₹0.77 and 5.9% above its 52-week low of ₹0.17. The share price is down 75.6% over one year and down 28.0% over three months.
| Current Price | ₹0.18 |
|---|---|
| Market Cap | ₹22 Cr |
| BSE Code | 524661 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Non-Prescription Drugs |
| P/E Ratio | -4.5 |
| Return on Equity | -5.50% |
| Return on Assets | -0.88% |
| 52-Week Range | ₹0.17 – ₹0.77 |
| 1-Year Price Change | -75.6% |
| 3-Month Price Change | -28.0% |
| Beta (1Y) | 1.27 |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.welcure.co.in |
Welcure Drugs and Pharmaceuticals Limited engages in trading of medical products in India. The company offers pharmaceutical and agri-tech development solutions. It also imports and exports its products. Welcure Drugs and Pharmaceuticals Limited was incorporated in 1996 and is based in Ahmedabad, India.
1. Providing Services for Procurement of Orders-This segment engages in providing services for procurements of orders related to pharmaceutical goods.
1. Agriculture-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd. | ₹40,739 Cr | 39.3 | 48.91% | ₹938 Cr | -11.7% |
| Alembic Pharmaceuticals Limited (Aplltd) | ₹14,941 Cr | 22.1 | 12.36% | ₹2,150 Cr | -18.6% |
| Bliss Gvs Pharma Ltd. | ₹6,683 Cr | 52.4 | 11.60% | ₹286 Cr | +308.7% |
| Zota Health Care Ltd | ₹4,304 Cr | -55.3 | -16.05% | ₹174 Cr | -17.5% |
| Amrutanjan Health Care Ltd. | ₹1,410 Cr | 24.3 | 16.62% | ₹103 Cr | -30.3% |
| Jenburkt Pharmaceuticals Ltd. | ₹380 Cr | 10.9 | 18.84% | — | -11.8% |
| Sat Kartar Life Limited | ₹205 Cr | 12 | — | — | — |
| Vista Pharmaceuticals Ltd. | ₹36 Cr | -7.4 | -10.82% | — | -37.7% |
| Welcure Drugs & Pharmaceuticals | ₹22 Cr | -4.5 | -5.50% | — | -75.6% |
Listed by market capitalisation. Ratios are shown for context only.
Welcure Drugs & Pharmaceuticals is trading at ₹0.18, with a market capitalisation of ₹22 Cr.
Welcure Drugs & Pharmaceuticals operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Non-Prescription Drugs).
Welcure Drugs & Pharmaceuticals has a P/E of -4.5 and a return on equity of -5.50%.
Welcure Drugs & Pharmaceuticals is listed on the BSE under the scrip code 524661.
Welcure Drugs & Pharmaceuticals's share price is down 75.6% over one year and down 28.0% over three months. Its 52-week range is ₹0.17 to ₹0.77.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.